SpyGlass Pharma, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 32.51 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.09B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.
Details
| Name | SpyGlass Pharma, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 76 |
| Founded | 2019 |
| Ipo Date | 2026-02-06 |
| Ceo | Patrick Mooney |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US85220G1094 |
| Cusip | 85220G109 |
| Cik | 1778922 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Patrick H. Mooney | Chief Executive Officer and Director |
| Dr. Malik Y. Kahook M.D. | Co-Founder, President, Chief Medical Officer and Executive Chairman |
| Dr. Chetan Pujara Ph.D. | Chief Research and Development Officer |
| Glenn Sussman | Co-founder and Chief Technology Advisor |
| Dr. Jean-Frederic Viret Ph.D. | Chief Financial Officer |
| James Robert Dennewill Jr. | Chief Operating Officer |
| Shannon Trevino J.D. | General Counsel |
| Mike Pinder | Vice President of Marketing |
| Rachel Gilette | Vice President of Human Resources |
| Paul Yoo O.D. | Senior Vice President of Clinical Development |
Contact
| Address | 15326 Alton Parkway, Irvine, California 92618, United States |
| Phone | 949 284 6904 |
| Website | https://www.spyglasspharma.com |